| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (5MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-588865
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.58886
Zusammenfassung
Multiple types of oncolytic viruses are currently under investigation in clinical trials. To optimize therapeutic outcomes it is believed that the plethora of different tumor types will require a diversity of different virus types. Sendai virus (SeV), a murine parainfluenza virus, displays a broad host range, enters cells within minutes and already has been applied safely as a gene transfer ...

Nur für Besitzer und Autoren: Kontrollseite des Eintrags


Downloadstatistik